Advanced search×

CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.

W Frank WF Peacock, Joseph J Varon, Brigitte M BM Baumann, Pierre P Borczuk, Chad M CM Cannon, Abhinav A Chandra, David M DM Cline, Deborah D Diercks, Brian B Hiestand, A A Hsu, Preeti P Jois-Bilowich, Brian B Kaminski, Philip P Levy, Richard M RM Nowak, and Jon W JW Schrock

crossref 15(3):R157 1 Jan 2011 PMID 21707983

Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension.

DOI: 10.1186/cc10289
Version: za2963e q8za6 q8zbe q8zc8 q8zd8 q8zec q8zf2 q8zg4
View PDF

Similar articles you may find interesting…

  1. Acute kidney injury and cardiovascular outcomes in acute severe hypertension.
    Lynda A Szczech, Christopher B Granger, ... Studying the Treatment of Acute Hypertension Investigators

    Circulation 121(20):2183-91 (2010) PMID 20458014

    Chronic kidney disease is a common comorbidity among patients admitted with acute severe hypertension, and AKI is a frequent form of acute target organ dysfunction, particularly in those with baseline chronic kidney disease. Any degree of AKI is associated with a greater risk of morbidity and mortal...
    Buy PDF
  2. European society of intensive care medicine study of therapeutic hypothermia (32-35 °C) for intracranial pressure reduction after traumatic ...
    Peter Jd Andrews, Helen Louise K Sinclair, ... Eurotherm3235trial Collaborators K Eurotherm Or Neurotherm

    Trials (2011) PMID 21226939

    View PDF